Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech Revenue

Sartorius Stedim Biotech had revenue of 761.50M EUR in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 2.98B, up 41.23% year-over-year. In the year 2025, Sartorius Stedim Biotech had annual revenue of 2.97B with 6.74% growth.

• Revenue (ttm): 2.98B
• Revenue Growth: +41.23%
• P/S Ratio: 5.75
• Revenue / Employee: 285.42K
• Employees: 10,456
• Market Cap: 17.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.97B	187.50M	6.74%
Dec 31, 2024	2.78B	4.50M	0.16%
Dec 31, 2023	2.78B	-717.20M	-20.53%
Dec 31, 2022	3.49B	605.70M	20.98%
Dec 31, 2021	2.89B	976.92M	51.15%
Dec 31, 2020	1.91B	469.51M	32.59%
Dec 31, 2019	1.44B	228.42M	18.84%
Dec 31, 2018	1.21B	131.12M	12.13%
Dec 31, 2017	1.08B	29.42M	2.80%
Dec 31, 2016	1.05B	167.28M	18.92%
Dec 31, 2015	884.33M	200.81M	29.38%
Dec 31, 2014	683.52M	95.15M	16.17%
Dec 31, 2013	588.38M	44.41M	8.16%
Dec 31, 2012	543.96M	66.66M	13.97%
Dec 31, 2011	477.30M	44.35M	10.24%
Dec 31, 2010	432.95M	31.72M	7.91%
Dec 31, 2009	401.23M	33.24M	9.03%
Dec 31, 2008	368.00M	99.16M	36.88%
Dec 31, 2007	268.84M	177.46M	194.22%
Dec 31, 2006	91.37M	5.63M	6.56%
Dec 31, 2005	85.74M	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error